Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  New England Journal of Medicine

• Publication date

  1998-05-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM199805143382004PMID 9580649
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure.

  1997cited by this paper
• Intrasplenic hepatocyte allotransplantation in dalmation dogs with and without cyclosporine immunosuppression.

  1997cited by this paper
• Acute Liver Failure: Hepatocyte transplantation in liver failure and inherited metabolic disorders

  1996cited by this paper
• Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium

  1996cited by this paper
• Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies.

  1996cited by this paper
• Use of human hepatocytes to study P450 gene induction.

  1996cited by this paper
• Current therapy for Crigler‐Najjar syndrome type 1: Report of a world registry

  1996cited by this paper
• The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.

  1995cited by this paper
• Conditional immortalization of gunn rat hepatocytes: An ex vivo model for evaluating methods for bilirubin‐UDP‐glucuronosyltransferase gene transfer

  1995cited by this paper
• Integration of transplanted hepatocytes into host liver plates demonstrated with dipeptidyl peptidase IV-deficient rats.

  1995cited by this paper
• Human fetal hepatocyte transplantation in patients with fulminant hepatic failure.

  1994cited by this paper
• Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia

  1994cited by this paper
• Artificial liver: A forthcoming attraction

  1993cited by this paper
• Orthotopic auxiliary liver transplantation for Crigler-Najjar syndrome type 1.

  1993cited by this paper
• Hepatocyte Transplantation in Man

  1992cited by this paper
• Principles of solid-organ preservation by cold storage.

  1988cited by this paper
• Crigler-Najjar syndrome types I and II. Clinical experience--King's College Hospital 1972-1978. Phenobarbitone, phototherapy and liver transplantation.

  1987cited by this paper
• Orthotopic liver transplantation for type I Crigler‐Najjar syndrome

  1986cited by this paper
• Bilirubin Mono‐ and diglucuronide formation by human liver In vitro: Assay by high‐pressure liquid chromatography

  1981cited by this paper
• Unconjugated bilirubin and an increased proportion of bilirubin monoconjugates in the bile of patients with Gilbert's syndrome and Crigler-Najjar disease.

  1977cited by this paper
• Congenital familial nonhemolytic jaundice with kernicterus.

  1952cited by this paper
• HEREDITARY ACHOLURIC JAUNDICEin a New Mutant Strain of Rats

  1938cited by this paper

• Cell therapy for liver disorders: past, present and future

  2025cites this paper
• Mitochondrial Activation and Therapeutics: Innovations in Cell- and Organelle-Specific Medicine.

  2025cites this paper
• Revolutionizing neonatal health: India's journey from assays to advanced genetics.

  2025cites this paper
• AAV capsid prioritization in normal and steatotic human livers maintained by machine perfusion

  2025cites this paper
• Perspectives and Tools in Liver Graft Assessment: A Transformative Era in Liver Transplantation

  2025cites this paper
• From cold chain to ambient: Benefits, risks, and evidence across cell therapy logistics

  2025cites this paper
• A novel approach for hepatocyte transplantation at the liver surface

  2025cites this paper
• In vivo selection of hepatocytes.

  2024cites this paper
• Kupffer cells abrogate homing and repopulation of allogeneic hepatic progenitors in injured liver site

  2024cites this paper
• Applying machine learning for multi-individual Raman spectroscopic data to identify different stages of proliferating human hepatocytes

  2024cites this paper
• Therapeutic Options for Crigler–Najjar Syndrome: A Scoping Review

  2024cites this paper
• Complete correction of murine phenylketonuria by selection-enhanced hepatocyte transplantation

  2023cites this paper
• Cell therapy in end-stage liver disease: replace and remodel

  2023cites this paper
• CRISPR-Cas9-mediated somatic correction of a one-base deletion in the Ugt1a gene ameliorates hyperbilirubinemia in Crigler-Najjar syndrome mice

  2023influential citation
• The protective effect of transplanted liver cells into the mesentery on the rescue of acute liver failure after massive hepatectomy(

  2023cites this paper
• Hepatocyte transplantation: The progress and the challenges

  2023cites this paper
• Toward Transplantation of Liver Organoids: From Biology and Ethics to Cost-effective Therapy

  2023cites this paper
• Lethality rescue and long-term amelioration of a citrullinemia type I mouse model by neonatal gene-targeting combined to SaCRISPR-Cas9

  2023cites this paper
• Irreversible Electroporation of the Liver Increases the Transplant Engraftment of Hepatocytes

  2023cites this paper
• The Effect of Genetic HLA Matching on Liver Transplantation Outcome: A Systematic Review and Meta-Analysis

  2023cites this paper
• Complete correction of murine phenylketonuria by selection-enhanced hepatocyte transplantation

  2023cites this paper
• CD47 and PD-L1 overexpression in proliferating human hepatocytes attenuated immune responses and ameliorated acute liver injury in mice.

  2023cites this paper
• Gene Therapy in Patients with the Crigler-Najjar Syndrome.

  2023cites this paper
• Cell and cell-derivative-based therapy for liver diseases: current approaches and future promises

  2023cites this paper
• Functional Assessment of Cardiac Arrest Hepatocytes and Effect of Mechanical Perfusion on Function in a Rat Model.

  2023cites this paper
• Human Hepatocyte Transplantation: Three Decades of Clinical Experience and Future Perspective

  2023cites this paper
• Multiple Dimensions of using Mesenchymal Stem Cells for Treating Liver Diseases: From Bench to Beside

  2023cites this paper
• Reprogramming the spleen into a functioning ‘liver’ in vivo

  2022cites this paper
• Generation of Human Liver Chimeric Mice and Harvesting of Human Hepatocytes from Mouse Livers.

  2022cites this paper
• Cellular Therapies in Pediatric Liver Diseases

  2022cites this paper
• 32 Cell Transplantation

  2022cites this paper
• Cellular therapies in liver and pancreatic diseases.

  2022cites this paper
• Cell Transplantation

  2021cites this paper
• Cell therapy in congenital inherited hepatic disorders.

  2021cites this paper
• CRISPR-targeted genome editing of human induced pluripotent stem cell-derived hepatocytes for the treatment of Wilson’s disease

  2021cites this paper
• Hepatic Regeneration in Cirrhosis.

  2021cites this paper
• Organoid transplant approaches for the liver

  2021cites this paper
• Cell-Based Regeneration and Treatment of Liver Diseases

  2021cites this paper
• Gene Therapy

  2021cites this paper
• The Applications of the Recellularization Organs in Organ Replacement at the Stage of Animal Research

  2021cites this paper
• Outcome of liver transplantation and prevalence of liver fibrosis in Crigler‐Najjar syndrome

  2021cites this paper
• Single cell Raman spectroscopy to identify different stages of proliferating human hepatocytes for cell therapy

  2021cites this paper
• Correction of a urea cycle defect after ex vivo gene editing of human hepatocytes

  2021cites this paper
• Scaffold-Free Biofabrication of Liver

  2021cites this paper
• Hepatocyte organoids and cell transplantation: What the future holds

  2021cites this paper
• Clinical perspective on the use of human amniotic epithelial cells to treat congenital metabolic diseases with a focus on maple syrup urine disease

  2021cites this paper
• Cholangiogenic potential of human deciduous pulp stem cell-converted hepatocyte-like cells

  2021cites this paper
• Challenges, highlights, and opportunities in cellular transplantation: A white paper of the current landscape

  2021cites this paper
• Transplantation of bioengineered liver capable of extended function in a preclinical liver failure model

  2021cites this paper
• Abnormalities of Hepatic Protein Metabolism

  2021cites this paper
• Preferable Transplant Site for Hepatocyte Transplantation in a Rat Model

  2021cites this paper
• Liver Repopulation by Cell Transplantation and the Role of Stem Cells in Liver Biology

  2020cites this paper
• Regenerative hepatology: In the quest for a modern prometheus?

  2020cites this paper
• Clinical application of hepatocyte transplantation: current status, applicability, limitations, and future outlook

  2020cites this paper
• Distinct EpCAM-Positive Stem Cell Niches Are Engaged in Chronic and Neoplastic Liver Diseases

  2020cites this paper
• Evolving Cell-Based and Cell-Free Clinical Strategies for Treating Severe Human Liver Diseases

  2020cites this paper
• Long-Term Survival of Transplanted Autologous Canine Liver Organoids in a COMMD1-Deficient Dog Model of Metabolic Liver Disease

  2020cites this paper
• Human liver stem cells express UGT1A1 and improve phenotype of immunocompromised Crigler Najjar syndrome type I mice

  2020cites this paper
• Infusion-related thrombogenesis by liver-derived mesenchymal stem cells controlled by anticoagulant drugs in 11 patients with liver-based metabolic disorders

  2020cites this paper
• Pluripotent-Stem-Cell-Derived Hepatic Cells: Hepatocytes and Organoids for Liver Therapy and Regeneration

  2020cites this paper
• α1-Antitrypsin Deficiency

  2020cites this paper
• Disease burden of Crigler–Najjar syndrome: Systematic review and future perspectives

  2020cites this paper
• High Dose Versus Low Dose Syngeneic Hepatocyte Transplantation in Pex1-G844D NMRI Mouse Model is Safe but Does Not Achieve Long Term Engraftment

  2020influential citation
• Evaluation and review of ways to differentiate sources of ethanol in postmortem blood

  2020cites this paper
• Development of Ectopic Livers by Hepatocyte Transplantation Into Swine Lymph Nodes

  2020cites this paper
• Disorders of Bilirubin Metabolism

  2020cites this paper
• Cell Therapy for Advanced Liver Diseases: Repair or Rebuild.

  2020cites this paper
• Development of Bioengineered Organ Using Biological Acellular Rat Liver Scaffold and Hepatocytes

  2020cites this paper
• A Quantitative In Vitro Potency Assay for Adeno-Associated Virus Vectors Encoding for the UGT1A1 Transgene

  2020cites this paper
• Induced Pluripotent Stem Cells for the Treatment of Liver Diseases: Novel Concepts

  2020cites this paper
• Hepatic tissue engineering

  2020cites this paper
• Stem Cell Therapy Delivery in Liver Disease

  2020cites this paper
• A brief review on Drug-induced hepatotoxicity: Use of hepatoprotective agents

  2020cites this paper
• Bile Pigment Metabolism and Its Disorders

  2020cites this paper
• Utility of Common Marmoset (Callithrix jacchus) Embryonic Stem Cells in Liver Disease Modeling, Tissue Engineering and Drug Metabolism

  2020cites this paper
• Improving Hepatocyte Engraftment Following Hepatocyte Transplantation Using Repeated Reversible Portal Vein Embolization in Rats

  2019cites this paper
• Xenobiotic-Induced Fetal Hepatocyte Maturation

  2019cites this paper
• Prospects for Cell-Directed Curative Therapy of Phenylketonuria (PKU)

  2019cites this paper
• Hyperbilirubinemia

  2019cites this paper
• Crigler najjar syndrome: A systematic outline

  2019cites this paper
• Towards Bioengineered Liver Stem Cell Transplantation Studies in a Preclinical Dog Model for Inherited Copper Toxicosis

  2019cites this paper
• Roles Of Euchromatin And Heterochromatin In Hepatocyte Maturation And Liver Fibrosis

  2019cites this paper
• Improving engraftment of hepatocyte transplantation using alpha-1 antitrypsin as an immune modulator

  2019cites this paper
• Functions and the Emerging Role of the Foetal Liver into Regenerative Medicine

  2019cites this paper
• Construction of sinusoid-scale microvessels in perfusion culture of a decellularized liver.

  2019cites this paper
• Macrophages as a Cell-Based Therapy for Liver Disease

  2019cites this paper
• Synthetic probes for in vitro purification and in vivo tracking of hepatocytes derived from human pluripotent stem cells.

  2019cites this paper
• Liver Transplantation for Inherited Metabolic Disorders

  2019cites this paper
• Regenerative cell therapy for the treatment of hyperbilirubinemic Gunn rats with fresh and frozen human induced pluripotent stem cells‐derived hepatic stem cells

  2019cites this paper
• Therapeutic potential of hepatocyte-like-cells converted from stem cells from human exfoliated deciduous teeth in fulminant Wilson’s disease

  2019cites this paper
• Cell Therapy in Acute and Chronic Liver Disease

  2019cites this paper
• Construction and Evaluation of a Subcutaneous Splenic Injection Port for Serial Intraportal Vein Cell Delivery in Murine Disease Models

  2019cites this paper
• Gene Therapy in Pediatric Liver Disease

  2019cites this paper
• Delivery of mRNA Therapeutics for the Treatment of Hepatic Diseases.

  2019cites this paper
• Human amnion epithelial stem cells as a therapy for liver disease

  2019influential citation
• Efficient Formation of Three Dimensional Spheroids of Primary Hepatocytes Using Micropatterned Multi-Well Plates

  2019cites this paper
• Novel strategy for hepatocyte transplantation using resected organ with hepatocellular carcinoma or cholangiocarcinoma after hepatectomy

  2019cites this paper
• Differential role of natural killer group 2D in recognition and cytotoxicity of hepatocyte‐like cells derived from embryonic stem cells and induced pluripotent stem cells

  2019cites this paper
• Ultrasound-guided in Utero Transplantation of Placental Stem Cells into the Liver of Crigler-Najjar Syndrome Model Rat.

  2019cites this paper
• In Utero Cell Transplantation as a Tool for Fixing Liver-based Inherited Metabolic Disorders: Early Technical Evidence Supporting Potential Feasibility.

  2019influential citation